The DOI matches its Crossref record; 172 of the 173 references it cites were found in a registry or an index, and 1 are not checked yet.
Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis
Open accessAbstract
Alzheimer's disease (AD) is a major public health problem with substantial economic and social impacts around the world. The hallmarks of AD pathogenesis include deposition of amyloid β (Aβ), neurofibrillary tangles, and neuroinflammation. For many years, research has been focused on Aβ accumulation in senile plaques, as these aggregations were perceived as the main cause of the neurodegeneration found in AD. However, increasing evidence suggests that inflammation also plays a critical role in the pathogenesis of AD. Microglia cells are the resident macrophages of the brain and act as the first line of defense in the central nervous system. In AD, microglia play a dual role in disease progression, being essential for clearing Aβ deposits and releasing cytotoxic mediators. Aβ activates microglia through a variety of innate immune receptors expressed on these cells. The mechanisms through which amyloid deposits provoke an inflammatory response are not fully understood, but it is believed that these receptors cooperate in the recognition, internalization, and clearance of Aβ and in cell activation. In this review, we discuss the role of several receptors expressed on microglia in Aβ recognition, uptake, and signaling, and their implications for AD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FCγR activation also promotes Aβ clearance via phagocytosis [139, 140].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglial LRP1 mediates Aβ uptake and activation of microglia (20–22).”
From LRPAP1 is released from activated microglia and inhibits microglial phagocytosis and amyloid beta aggregation (2023) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Aβ fibrils also increase inflammation148 (Fig. 5, purple), which may unanchor residual PDE4A125, and further disinhibit stress signaling pathways.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [148]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In mouse macrophages and COS cells, SHIP1 was shown to activate the ITIM of the inhibitory receptor FCγRIIβ, which inhibits the activating receptor FCγRIIA to block FCγRIIA-mediated phagocytosis (Fig. 3C).”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [140]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“SHIP1 also was shown to directly inhibit FCγRIIA by binding to its ITAM (Fig. 3C), which prevents the activation of PI3K [134, 137–140].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
Delrieu, J., Ousset, P., Caillaud, C., & Vellas, B. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07458.x · Cited by 147
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
Lemaître, B., Nicolas, E., Michaut, L., Reichhart, J., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,224
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Research works printed but not linked: 1
- 10.1146/annurev.bi.63.070194.003125 · DOI
Cited by
Sorted by citations
Items 201–300 of 349
Lin, J., Gao, S., Wang, T., Shen, Y., Yang, W., Li, Y., & Hu, H. (2019) · PubMed Central · Cited by 20
The interplay between neuroinflammatory pathways and Parkinson's disease
Ocak, P. E., Kocabıçak, E., Bekâr, A., & Temel, Y. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114644 · Cited by 20
Freude, K., Pires, C., Hyttel, P., & Hall, V. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041402 · Cited by 21
Plasma Membrane Protein Profiling in Beta‐Amyloid‐Treated Microglia Cell Line
Correani, V., Francesco, L. D., Mignogna, G., Fabrizi, C., Leone, S., Giorgi, A., Passeri, A., Casata, R., Fumagalli, L., Maras, B., et al. (2017) · PROTEOMICS · doi:10.1002/pmic.201600439 · Cited by 20
Cheng, Y., Chang, C., Chang, T., Li, H., Hung, H., Liu, G., & Lin, C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27659 · Cited by 20
Welcome, M. O. (2018) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000492491 · Cited by 22
Alzheimer’s disease basics: we all should know
Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19
The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
Busch, L., Eggert, S., Endres, K., & Bufe, B. (2022) · Cells · doi:10.3390/cells11213421 · Cited by 20
Sepulveda, J., Kim, J. Y., Binder, J., Vicini, S., & Rebeck, G. W. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00714-y · Cited by 19
Reprint of: Microglial toll-like receptors and Alzheimer’s disease
Su, F., Bai, F., Zhou, H., & Zhang, Z. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.016 · Cited by 19
Fahim, V. F., Wadie, W., Shafik, A. N., & Attallah, M. I. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.012 · Cited by 19
Genome-wide association findings from the brains for dementia research cohort
Young, J., Gallagher, E., Koska, K., Guetta‐Baranes, T., Morgan, K., Thomas, A. J., & Brookes, K. J. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.014 · Cited by 20
Tau and Amyloid beta causes microglial activation in Alzheimer’s disease
Chinnathambi, S., Adithyan, A., Chandrashekar, M., & Rangappa, N. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.06.002 · Cited by 19
Tiwari, R. K., Moin, A., Rizvi, S. M. D., Shahid, S. M. A., & Bajpai, P. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00696-6 · Cited by 19
Study of Exosomes Shed New Light on Physiology of Amyloidogenesis
van Niel, G. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0357-0 · Cited by 20
Cheng, B. H., Lin, Y., Kuang, M., Fang, S., Gu, Q., Xu, J., & Wang, L. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12581 · Cited by 18
Ali, M. U., Anwar, L., Ali, M. H., Iqubal, M. K., Iqubal, A., Baboota, S., & Ali, J. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666221223091529 · Cited by 17
Photoacoustic imaging in brain disorders: Current progress and clinical applications
Liu, X., Li, H., Pang, M., Liu, J., Song, X., He, R., He, M., Jian, X., Ma, C., Deng, H., et al. (2024) · Open Research (University of Surrey) · doi:10.1002/viw.20240023 · Cited by 17
Pramanik, S., Harini Devi, M., Chakrabarty, S., Paylar, B., Pradhan, A., Thaker, M., Ayyadhury, S., Manavalan, A., Olsson, P., Pramanik, G., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105834 · Cited by 18
Fukuishi, N., Takahama, K., Kurosaki, H., Ono, S., & Asai, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041491 · Cited by 18
Modulation of Aging Diseases via RAGE Targets: A Dietary Intervention Review
Wu, Q., Yan, J., Zhang, Y., Ming, X., Chen, S., Zou, Z., Feng, N., & Xiao, J. (2025) · Advanced Science · doi:10.1002/advs.202510242 · Cited by 16
Bridging pathway dysfunction and therapy: novel compounds for neuroprotection
Patel, S., Prajapati, C., Nand, S., & Singh, S. K. (2026) · 3 Biotech · doi:10.1007/s13205-026-04697-z · Cited by 16
Smit, T., Ormel, P. R., Sluijs, J. A., Hulshof, L. A., Middeldorp, J., de Witte, L. D., Hol, E. M., & Donega, V. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.12.001 · Cited by 16
Varshavskaya, K. B., Mitkevich, V. A., Makarov, A. А., & Barykin, E. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315036 · Cited by 18
VEGF controls microglial phagocytic response to amyloid-β
Gea, P. D., Benkeder, S., Bouvet, P., Aimard, M., Chounlamountri, N., Honnorat, J., Do, L.-D., & Meissirel, C. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1264402 · Cited by 19
Distribution and characterization of tumor-associated macrophages/microglia in rat C6 glioma
Zhang, Z., Yang, Z., & Zhang, Z. (2015) · Oncology Letters · doi:10.3892/ol.2015.3533 · Cited by 16
Wei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102544 · Cited by 15
Dagla, I., Gkikas, F., Gikas, E. E., & Tsarbopoulos, A. (2026) · Cells · doi:10.3390/cells15030295 · Cited by 16
Hu, X., Liu, C., Wang, K., Zhao, L., Qiu, Y. L., Chen, H., Hu, J., & Xu, J. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.842208 · Cited by 15
Shahbaz, S. K., Koushki, K., Hedayati, S. K., McCloskey, A. P., Kesharwani, P., Naderi, Y., & Sahebkar, A. (2024) · Medicinal Research Reviews · doi:10.1002/med.22064 · Cited by 15
Emerging microglial biology highlights potential therapeutic targets for Alzheimer's disease
Fan, X., Chen, H., He, W., & Zhang, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102471 · Cited by 16
Philippens, I. H. C. H. M., & Langermans, J. A. M. (2021) · Vaccines · doi:10.3390/vaccines9040388 · Cited by 16
Neutrophil Granule Proteins Inhibit Amyloid Beta Aggregation and Neurotoxicity
Kasus‐Jacobi, A., Washburn, J. L., Land, C. A., & Pereira, H. A. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210823095044 · Cited by 15
Njoku, G. C., & Kanmogne, G. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189069 · Cited by 15
Wang, X., Zhang, S., Li, Y., & Zhang, Y. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae154 · Cited by 14
Shinjyo, N., Hikosaka, K., Kido, Y., Yoshida, H., & Norose, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603924 · Cited by 14
Busch, L., Taleb, Z. A., Tsai, Y., Nguyen, V. T. T., Lu, Q., Synatschke, C. V., Endres, K., & Bufe, B. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102642 · Cited by 14
Peña‐Ortega, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160928151546 · Cited by 14
The Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target
Liu, G., Zhang, L., Fan, Y., & Ji, W. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206150 · Cited by 13
Reid, K. M., & Brown, G. C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286474 · Cited by 13
Huang, L., Liu, M., Li, Z., Li, B., Wang, J., & Zhang, K. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00865 · Cited by 13
Bagheri, S., Saboury, A. A., Haertlé, T., Rongioletti, M. C. A., & Saso, L. (2022) · Inorganics · doi:10.3390/inorganics10010006 · Cited by 14
An insight into the TAM system in Alzheimer’s disease
Zhou, S., Li, Y., Zhang, Z., & Yuan, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109791 · Cited by 14
Samuels, J. D., Lukens, J. R., & Price, R. J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15981 · Cited by 13
Macrophages and Tissue Homeostasis: From Physiological Functions to Disease Onset
Li, Y., Chen, H., & Zhou, S. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl42706 · Cited by 12
Liver Growth Factor “LGF” as a Therapeutic Agent for Alzheimer’s Disease
Gonzalo‐Gobernado, R., Perucho, J., Vallejo-Muñoz, M., Casarejos, M. J., Reimers, D., Jiménez‐Escrig, A., Gómez, A., de Asanza, G. M. U., & Bazán, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239201 · Cited by 13
Moayedi, K., Orandi, S., Ebrahimi, R., Tanhapour, M., Moradi, M., Abbastabar, M., & Golestani, A. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30779 · Cited by 12
Advances in proteomic phenotyping of microglia in neurodegeneration
Sunna, S. N., Bowen, C. A., Ramelow, C. C., Santiago, J. V., Kumar, P., & Rangaraju, S. (2023) · PROTEOMICS · doi:10.1002/pmic.202200183 · Cited by 13
Shaik, S. M., Cao, Y., Gogola, J. V., Dodiya, H. B., Zhang, X., Boutej, H., Han, W., Križ, J., & Sisodia, S. S. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00668-7 · Cited by 12
Bashore, F. M., Katis, V. L., Du, Y., Sikdar, A., Wang, D., Bradshaw, W. J., Rygiel, K. A., Leisner, T. M., Chalk, R., Mishra, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0293548 · Cited by 12
Wang, Y.-J., Downey, M. A., Choi, S., Shoup, T. M., & Elmaleh, D. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-00465-6 · Cited by 14
Role of canonical and noncanonical autophagy pathways in shaping the life journey of B cells
Wang, Y., Wu, L., & Kaer, L. V. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1426204 · Cited by 13
Jiao, H., Ge, Y., Huang, L.-Y., Liu, Y., Wu, B., Lian, P., Hao, Y., Han, S., Li, Y., Wu, K., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00887-0 · Cited by 11
Beyond amyloid: nanobody-mediated neuroinflammatory therapy for Alzheimer’s disease
Amniouel, S., Suh, J., Zheng, W. H., & Zhang, Q. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00513-5 · Cited by 11
Steffen, J., Stenzel, J., Ibrahim, S. M., & Pahnke, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180395 · Cited by 11
Wang, X., Li, Y., Wang, Y., Feng, Q., Yang, P., & Qin, L. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.576994 · Cited by 11
Lee, J., Mizuno, K., Watanabe, H., Lee, I., Tsumita, T., Hida, K., Yawaka, Y., Kitagawa, Y., Hasebe, A., Iimura, T., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03192-7 · Cited by 14
Augusto‐Oliveira, M., Tremblay, M., & Verkhratsky, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_6 · Cited by 10
Microbiota and Alzheimer’s disease: mechanistic insights from a multi-organ perspective
Liao, J., Mou, H., Luo, S., Shen, L., & Jiao, B. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00541-9 · Cited by 11
Zhang, J., Yao, P., Han, W., Luo, Y., Li, Y., Yang, Y., Xia, H., Chen, Z., Chen, Q., Wang, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116142 · Cited by 10
Connectome-based biophysics models of Alzheimer’s disease diagnosis and prognosis
Torok, J., Anand, C., Verma, P., & Raj, A. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.008 · Cited by 11
Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer’s Disease
Cheng, J., Zheng, H., Liu, C., Jin, J., Xing, Z., & Wu, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221143 · Cited by 10
Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
Islam, M. R., Rabbi, M. A., Hossain, T., Sultana, S., & Uddin, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00360 · Cited by 10
Udomruk, S., Wudtiwai, B., Shwe, T. H., Phitak, T., Pothacharoen, P., Phimphilai, M., & Kongtawelert, P. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.012 · Cited by 10
Mechanistic Role of Jak3 in Obesity-Associated Cognitive Impairments
Kumar, P., Mishra, J., & Kumar, N. (2022) · Nutrients · doi:10.3390/nu14183715 · Cited by 10
Selecting Multitarget Peptides for Alzheimer’s Disease
Kasus‐Jacobi, A., Washburn, J. L., Laurence, R. B., & Pereira, H. A. (2022) · Biomolecules · doi:10.3390/biom12101386 · Cited by 10
Малашенкова, И. К., Hailov, N. A., Krynskiy, S., Ogurtsov, D., Kazanova, G. V., Velichkovckiy, B. B., Селезнева, Н. Д., Fedorova, Y. B., Пономарева, Е. В., Колыхалов, И. В., et al. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20161163139-43 · Cited by 9
Jeong, J. Y., Wi, R., Chung, Y. C., & Jin, B. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073486 · Cited by 8
The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis
Li, B., Chen, M., Aguzzi, A., & Zhu, C. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02061-7 · Cited by 7
Elucidating the molecular targets in Alzheimer's disease: Advances and therapeutic implications
Soni, U., & Pujari, R. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111660 · Cited by 7
Neuron-Microglia Crosstalk in Neuropsychiatric Disorders
Jeon, S. W., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_1 · Cited by 7
Fan, J., Ma, Z., Zheng, Y., Zhang, M., Huang, L., & Liu, H. (2023) · Nutrients · doi:10.3390/nu15163501 · Cited by 7
Zheng, H., Mizokami, A., Romera-Giner, S., Llera-Oyola, J., Yamawaki, Y., Sano, T., Jimi, E., Garcia‐García, F., & Kanematsu, T. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00686-8 · Cited by 7
Kim, B., Lim, H.-S., Kim, Y. J., Sohn, E., Kim, Y. H., Koo, I., & Jeong, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-59537-8 · Cited by 8
Sharman, M. J., Verdile, G., Kirubakaran, S., & Münch, G. W. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch8 · Cited by 8
Shao, X., Sun, J., Wang, X., Yin, X., Chen, Z., Xu, Y., Wang, T., Yuan, B., Qiu, W., Liu, F., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00475 · Cited by 6
Halimi, H., Ahmadi, B., Asri, N., Rostami‐Nejad, M., & Houri, H. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107363 · Cited by 7
Investigation of patterns and associations of neuroinflammation in cognitive impairment
Gan, R., Xie, H., Zhao, Z., Wu, X., Wang, R., Wu, B., Chen, Q., & Jia, Z. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf013 · Cited by 7
Mathematical Modeling of Neuroinflammation in Neurodegenerative Diseases
Foster‐Powell, A., Rostami‐Hodjegan, A., Meno‐Tetang, G. M. L., Mager, D. E., & Ogungbenro, K. (2025) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70064 · Cited by 7
Does a pickle a day keep Alzheimer's away? Fermented food in Alzheimer's disease: A review
Tyliszczak, M., Wiatrak, B., Danielewski, M., Szeląg, A., Kucharska, A. Z., & Sozański, T. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112332 · Cited by 6
Hodgson, L. M., Li, Y., Iturria‐Medina, Y., Stratton, J. A., Wolf, G., Krishnaswamy, S., Bennett, D. A., & Bzdok, D. (2024) · Communications Biology · doi:10.1038/s42003-024-06273-8 · Cited by 7
Krynskiy, S., Малашенкова, И. К., Ogurtsov, D., Khailov, N. A., Chekulaeva, E. I., Shipulina, O. Y., Пономарева, Е. В., Si, G., Didkovsky, N. A., & Velichkovsky, B. B. (2021) · Problems of Virology · doi:10.36233/0507-4088-32 · Cited by 5
Talele, S., González, S., Trudeau, J., Ahmad, J., Loy, C. A., Altman, R. A., & Sjögren, B. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01738 · Cited by 5
Anastasi, F., Genius, P., Rodríguez‐Fernández, B., Yang, C., Gorijala, P., Timsina, J., Hernández‐Villamizar, L. F., Lorenzini, L., del Campo, M., Sánchez‐Benavides, G., et al. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.10.003 · Cited by 5
Huang, Q., Zhou, Y., He, H., Lin, S., & Chen, X. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03785-9 · Cited by 5
Iron blocks autophagic flux and induces autophagosomes accumulation in microglia
Fu, D., Liang, X., Jiang, Y., Liu, J., Lin, X., Yang, Q., Chen, X., Huang, P., Wang, W. J., & Wu, W. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114054 · Cited by 5
Pérez, R., Burgos, V., Cabrera‐Pardo, J. R., Ortíz, L., Camins, A., Ettcheto, M., Schmidt, B., Nchiozem‐Ngnitedem, V., & Paz, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062419 · Cited by 4
Li, G., Xiao-qing, F., Wang, W., Li, J., Shi, Y., Wang, L., & Hu, C. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106767 · Cited by 4
Малашенкова, И. К., Хайлов, Н. А., Krynskiy, S., Ogurtsov, D., Kazanova, G. V., Velichkovskii, B. B., Селезнева, Н. Д., Fedorova, Y. B., Пономарева, Е. В., Колыхалов, И. В., et al. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0457-4 · Cited by 4
Neuroimmune Dynamics in Alzheimer’s Disease Progression
Andrade, V., Guzmán‐Martínez, L., Vergara-Pulgar, K., & Maccioni, R. B. (2017) · InTech eBooks · doi:10.5772/intechopen.68941 · Cited by 4
Zhou, Y., Huang, Y., Fan, Y., & Xue, F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0337741 · Cited by 3
Morovati, A., Moussa, Y., Kalupahana, N. S., Zu, Y., Jun, H., Fokar, M., & Moustaïd‐Moussa, N. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101407 · Cited by 3
Oxycodone induces HMGB1-mediated neuroimmune crosstalk between oligodendrocytes and microglia
Maulik, M., Rose, C., Mallick, S., Jones, A., Dodge, A., Chakraborty, S., Carter, A., Jeffers, A., Ford, M., Zhang, E., et al. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.02.037 · Cited by 3
Medeiros, E. B., Lídio, A. V., Zabot, G. C., Fenilli, G. P., Silveira, G. D. B., Keller, G. S., Carrion, F. R. A., Felice, F. G. D., Kluwe‐Schiavon, B., Walss‐Bass, C., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-10927-w · Cited by 3
Mazziotti, V., Carone, L. D. S., Olmeo, F., Chiodo, F., Silipo, A., Molinaro, A., & Lorenzo, F. D. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1796397 · Cited by 3
Protein glycoxidation in neuropsychiatric disorders—from basic research to clinical practice
Orlof, W., & Maciejczyk, M. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104190 · Cited by 3
The Endocannabinoid System in Local and Systemic Inflammation
Kelly, M. E. M., Lehmann, C., & Zhou, J. (2017) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00151ed1v01y201702isp074 · Cited by 4
A review on brain-targeting nano-based drug delivery
Li, P., Chen, Y., Gao, X., & Jiang, G. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-1147 · Cited by 3
MICROGLIAL PHAGOCYTOSIS IN RATS WITH DIFFERENT MODELS OF ALZHEIMER'S DISEASE
Nefedova, A. (2023) · Biotechnologia Acta · doi:10.15407/biotech16.01.057 · Cited by 3
Zhang, Y., Wu, Y., Zhang, X., Guo, S., He, J., Hu, N., Huang, Y., Kong, Y., Li, Q., Sui, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70124 · Cited by 2
Metadata
- Authors
- Doens, D., & Fernández, P. L.
- Affiliations
- Acharya Nagarjuna University (IN)
- Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (PA)
- Corresponding author
- Fernández, Patricia L
- Venue
- Journal of Neuroinflammation
- Published
- 2014
- Volume
- 11
- Issue
- 1
- Pages
- 48
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC3975152
- OpenAlex
- W2100011299
- Cited by
- 348
- References
- 172
- Citations by year
- 2026: 22 · 2025: 42 · 2024: 33 · 2023: 33 · 2022: 36 · 2021: 27 · 2020: 24 · 2019: 24 · 2018: 27 · 2017: 26 · 2016: 24 · 2015: 25 · 2014: 5
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Greater South Information System
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, microglia, innate immune receptors, neuroinflammation, amyloid clearance, receptor signaling, microglial activation, amyloid plaques, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Humans, Receptors, Immunologic, Amyloid beta-Peptides, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review